On Tuesday, BioRestorative Therapies Inc (NASDAQ: BRTX) was -0.76% down from the session before settling in for the closing price of $1.32. A 52-week range for BRTX has been $1.20 – $7.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 23.65% over the past five years. When this article was written, the company’s average yearly earnings per share was at 37.72%. With a float of $4.90 million, this company’s outstanding shares have now reached $6.77 million.
Let’s look at the performance matrix of the company that is accounted for 11 employees.
BioRestorative Therapies Inc (BRTX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward BioRestorative Therapies Inc stocks. The insider ownership of BioRestorative Therapies Inc is 27.60%, while institutional ownership is 11.39%. The most recent insider transaction that took place on Apr 09 ’24, was worth 8,250. In this transaction VP of Research and Development of this company bought 6,600 shares at a rate of $1.25, taking the stock ownership to the 155,759 shares. Before that another transaction happened on Apr 08 ’24, when Company’s VP of Research and Development bought 1,708 for $1.16, making the entire transaction worth $1,979. This insider now owns 149,159 shares in total.
BioRestorative Therapies Inc (BRTX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 37.72% per share during the next fiscal year.
BioRestorative Therapies Inc (NASDAQ: BRTX) Trading Performance Indicators
You can see what BioRestorative Therapies Inc (BRTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 59.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.54, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.10 in one year’s time.
Technical Analysis of BioRestorative Therapies Inc (BRTX)
BioRestorative Therapies Inc (NASDAQ: BRTX) saw its 5-day average volume 2.18 million, a positive change from its year-to-date volume of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 53.22%. Additionally, its Average True Range was 0.11.
During the past 100 days, BioRestorative Therapies Inc’s (BRTX) raw stochastic average was set at 4.45%, which indicates a significant decrease from 22.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.48% in the past 14 days, which was lower than the 154.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4027, while its 200-day Moving Average is $1.9662. Nevertheless, the first resistance level for the watch stands at $1.5527 in the near term. At $1.7955, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9409. If the price goes on to break the first support level at $1.1645, it is likely to go to the next support level at $1.0191. Assuming the price breaks the second support level, the third support level stands at $0.7763.
BioRestorative Therapies Inc (NASDAQ: BRTX) Key Stats
There are 6,770K outstanding shares of the company, which has a market capitalization of 8.87 million. As of now, sales total 150 K while income totals -14,420 K. Its latest quarter income was 20 K while its last quarter net income were -2,830 K.
